(Q27015830)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Stefano Porcelli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Alessandro Serretti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Fabbri C

1

1 reference

Porcelli S

2

1 reference

Serretti A

3

1 reference

language of work or name

1 reference

1 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Psychiatry

19 March 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

59

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

62-75

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

A genomewide association study of citalopram response in major depressive disorder

19 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Genetics of psychosis; insights from views across the genome

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The endophenotype concept in psychiatry: etymology and strategic intentions

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

A framework for interpreting genome-wide association studies of psychiatric disorders

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Chaperoning of glucocorticoid receptors

21 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

21 March 2017

https://api.crossref.org/works/10.1177%2F070674371405900202

Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

5-HT1A receptors, gene repression, and depression: guilt by association

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Invited review: the evolution of antidepressant mechanisms

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

A functional polymorphism in the monoamine oxidase A gene promoter

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

High dimensional endophenotype ranking in the search for major depression risk genes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Mechanisms of antidepressant action: an integrated dopaminergic perspective

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Identification and functional characterization of three novel alleles for the serotonin transporter-linked polymorphic region

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Pharmacogenetics of antidepressant response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Genome-wide association studies of antidepressant outcome: a brief review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Statistical methods for pathway analysis of genome-wide data for association with complex genetic traits

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Antidepressant response and the serotonin transporter gene-linked polymorphic region

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

BDNF Val66Met genotype and 6-month remission rates in late-life depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

FKBP5 polymorphisms and antidepressant response in geriatric depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Population genetic study of the brain-derived neurotrophic factor (BDNF) gene

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

SLC6A4 variation and citalopram response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Sexually dimorphic effect of catechol-O-methyltransferase val158met polymorphism on clinical response to fluoxetine in major depressive patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Pharmacogenetic studies in depression: a proposal for methodologic guidelines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Does dopamine dysfunction drive depression?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

No gene is an island: the flip-flop phenomenon

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Serotonin transporter gene variants and behavior: a comprehensive review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Number of risk genotypes is a risk factor for major depressive disorder: a case control study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The AmpliChip CYP450 genotyping test: Integrating a new clinical tool

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Sequence analysis of the serotonin transporter and associations with antidepressant response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Genetic variants in the angiotensin I-converting-enzyme (ACE) and angiotensin II receptor (AT1) gene and clinical outcome in depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Dopamine, depression and antidepressants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Clinical aspects of the MDR1 (ABCB1) gene polymorphism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Discovering endophenotypes for major depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Treatment of mood disorders

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The corticosteroid receptor hypothesis of depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Allelic variation of human serotonin transporter gene expression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Dopamine and depression: a review of recent evidence. I. Empirical studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The role of dopamine in depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The genetics of antipsychotic induced tremors: a genome-wide pathway analysis on the STEP-BD SCP sample

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

DNA sequence variants of the FKBP5 gene are associated with unipolar depression

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Relationship between G-protein beta-3 subunit C825T polymorphism and mirtazapine responses in Korean patients with major depression

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Allelic Variation of Human Serotonin Transporter Gene Expression

31 May 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Norepinephrine and serotonin transporter genes: impact on treatment response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Tryptophan hydroxylase-2 controls brain serotonin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

MAOA gene polymorphisms and response to mirtazapine in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Dopamine and depression: A review of recent evidence. I. Empirical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Genetic variants in FKBP5 affecting response to antidepressant drug treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Bringing genetics back to psychiatric endophenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Investigation of serotonin-related genes in antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Moderation of antidepressant response by the serotonin transporter gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin transporter promoter gene polymorphism and long-term outcome of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin transporter gene polymorphisms and sertraline response in major depression patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

5-HTTLPR modulates antidepressant efficacy in depressed women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

A meta-analysis of depression severity and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin transporter gene and response to lithium augmentation in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association study of serotonin 1B receptor (A-161T) genetic polymorphism and suicidal behaviors and response to fluoxetine in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Monoamine oxidase A gene polymorphism, 5-HT 2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

HTR2A gene variation is involved in antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Genetic predictors of response to antidepressants in the GENDEP project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

No association between the tryptophan hydroxylase gene polymorphism and major depressive disorders and antidepressant response in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

TPH1 is associated with major depressive disorder but not with SSRI/SNRI response in Taiwanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Lack of association of TPH2 exon XI polymorphisms with major depression and treatment resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

The role of clinical variables, neuropsychological performance and SLC6A4 and COMT gene polymorphisms on the prediction of early response to fluoxetine in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Pharmacogenetics of selective serotonin reuptake inhibitor response: a 6-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association study of a brain‐derived neurotrophic‐factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and the early response to antidepressant in Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

SSRIs antidepressant activity is influenced by G beta 3 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Functional genomics approaches in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Variation in GNB3 predicts response and adverse reactions to antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Association study of angiotensin I-converting enzyme polymorphism and symptomatology and antidepressant response in major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Antidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Interaction between genetic polymorphisms and stressful life events in first episode depression

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4079233

Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder

28 November 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371405900202

The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study

21 January 2018

1 reference

12 December 2020

Serotonin transporter gene polymorphism and antidepressant response

1 reference

12 December 2020

Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment

1 reference

12 December 2020

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

12 December 2020

Tryptophan hydroxylase 2 (TPH2) haplotypes predict levels of TPH2 mRNA expression in human pons

1 reference

12 December 2020

Mode of inheritance in mood disorder families according to fluvoxamine response

1 reference

12 December 2020

Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness

1 reference

12 December 2020

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

1 reference

12 December 2020

Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression

1 reference

12 December 2020

A splice variant of the G protein beta 3-subunit implicated in disease states does not modulate ion channels

1 reference

12 December 2020

Patient-control association study of substance P-related genes in unipolar and bipolar affective disorders

1 reference

12 December 2020

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

12 December 2020

Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities

1 reference

12 December 2020

ABCB1 (P-glycoprotein/MDR1) gene G2677T/a sequence variation (polymorphism): lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline

1 reference

12 December 2020

The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men

1 reference

12 December 2020

Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment

1 reference

12 December 2020

Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders

1 reference

12 December 2020

Association of the COMT val158met variant with antidepressant treatment response in major depression

1 reference

12 December 2020

Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects

1 reference

12 December 2020

Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on therapeutic outcome in affective disorders

1 reference

12 December 2020

Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder

1 reference

12 December 2020

10.1177/070674371405900202

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

4098955

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

4098955

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24881125%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

2 references

Consolidated OpenCitations Corpus – April 2017

4098955